Sheep anti Human Glypican-3 (GPC3)

Sheep anti Human Glypican-3 (GPC3), Polyclonal, IgG
SKU
EXAX2395P
Packaging Unit
500 µg
Manufacturer
Exalpha Biologicals Inc

Availability: loading...
Price is loading...
Background: Glypican-3 encodes a putative extracellular proteoglycan that is inferred to play an important role in growth control in embryonic mesodermal tissues in which it is selectively expressed. It appears to form a complex with insulin-like growth factor and hence modulate IGF2 action. Glypican-3 is the human homolog of OCI-5, a GPI-linked proteoglycan first isolated from rat intestine. Originally identified as the molecular basis for Simpson-Golabi-Behmel syndrome (SGBS) also called Simpson dysmorphia syndrome (SDYS).

Immunogen: C terminal recombinant protein (~70aa) which does not overlap with clone 1G12 epitope).

Purification Method: Total IgG.

Formulation: Provided as solution in phosphate buffered saline with 0.08% sodium azide.

References: 1. Lai, J.P., et al. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology 2008, 47, 1211-1222.
2. Zynger, D.L., et al. Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Am. J. Clin. Pathol. 2008, 130, 224-230.
3. Anatelli, F., et al. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy. Am. J. Clin. Pathol. 2008, 130, 219-223.
4. Yamanaka, K., et al. Immunohistochemical study of glypican 3 in thyroid cancer. Oncology 2007, 73, 389-394.
5. Filmus, J., et al. Glypicans. Genome Biol. 2008, 9, 224.
6. Baumhoer, D., et al. Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am. J. Clin. Pathol. 2008, 129, 899-906.
7. Capurro, M.I., et al. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev. Cell 2008, 14, 700-711.
8. Motomura, Y., et al. HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: preclinical study using mice. Int. J. Oncol. 2008, 32, 985-990.
9. Cheng, W., et al. Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway. Carcinogenesis 2008, 29, 1319-1326.

UniProt: P51654.

Caution: This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.
More Information
SKU EXAX2395P
Manufacturer Exalpha Biologicals Inc
Manufacturer SKU X2395P
Green Labware No
Package Unit 500 µg
Quantity Unit STK
Reactivity Human
Clonality Polyclonal
Application Immunohistochemistry (paraffin), Western Blotting
Isotype IgG
Host Sheep
Product information (PDF) Download
MSDS (PDF) Download